FTI Portfolio Company RegCell’s Scientific Founder, Professor Shimon Sakaguchi, Awarded the 2025 Nobel Prize in Physiology or Medicine

  Tokyo, Japan / Cambridge, Massachusetts - Fast Track Initiative (FTI) joins in celebrating Pr...

Metagen Therapeutics Reports Clinical Readout From Ulcerative Colitis FMT Study

Metagen Therapeutics, Inc. (President and CEO: Taku Nakahara, PhD, MBA; Headquarters: Yamagata, Jap...

FTI Announces Additional Investment in Neusignal Therapeutics to Develop Alzheimer's Treatment 

Fast Track Initiative (FTI) has made a follow-on investment in Neusignal Therapeutics (CEO: Yoshifum...

AbbVie Acquires Celsius Therapeutics

  Celsius Therapeutics (President and CEO: Tariq Kassum, MD; Headquarters: Cambridge, USA), has...

Varinos Continues Research On New Genome Technology In Series C Funding

  Varinos (CEO: Yoshiyuki Sakuraba; Headquarters: Koto, Tokyo, Japan) announced their Series C ...

mediPhone Raises Over 1.1B JPY, Aiming To Resolve Language Barriers In Medical Care

  mediPhone (CEO Mayumi Sawada; Headquarters: Minato-ku, Tokyo, Japan), a HealthTech startup co...

Cellshoot Therapeutics Develops Groundbreaking Cell Analysis Technology For New Drug Discovery, Announcing 230M JPY In Seed Funding Round

  Cellshoot Therapeutics (CEO: Hiroshi Tanaka; Headquarters: Koto, Tokyo, Japan; hereinafter re...

reverSASP Therapeutics Completes Its Seed Round Funding To Address Age-Related Diseases

  reverSASP Therapeutics (Headquarters: Bunkyo City, Tokyo, Japan; hereinafter referred to as "...